Table 4.
Sensitivity Analysis of Tdap Vaccination Coverage, Healthcare Personnel Internet Panel Survey, 2012–2014, U.S.
| April 2012 survey
|
April 2013 survey
|
April 2014 survey
|
||||
|---|---|---|---|---|---|---|
| Sensitivity analysis |
Sample size, n |
% vaccinated (95% CI) |
Sample size, n |
% vaccinated (95% CI) |
Sample size, n |
% vaccinated (95% CI) |
| Overall Tdap vaccination | 2,038 | 34.8 (30.6, 39.0) | 1,613 | 40.2 (36.1, 44.4) | 1,633 | 42.4 (38.7, 46.0) |
|
| ||||||
| Lower bounda | 2,038 | 29.1 (25.9, 32.3) | 1,613 | 33.6 (30.1, 37.2) | 1,633 | 35.0 (31.7, 38.4) |
|
| ||||||
| Upper boundb | 2,038 | 48.4 (44.7, 52.1) | 1,613 | 51.3 (47.5, 55.2) | 1,633 | 56.0 (52.4, 59.6) |
a
All excluded respondents (those who answered my doctor did not say or not sure to the question about the type of tetanus vaccination received) were assumed to be unvaccinated with Tdap vaccination.
b
All excluded respondents (those who answered my doctor did not say or not sure to the question about the type of tetanus vaccination received) were assumed to be vaccinated with Tdap vaccination.
Tdap, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine.